More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.
In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to emerge in late responders.
Find out how vagus nerve stimulation delivers durable symptom relief and quality of life gains in treatment resistant depression patients.
ROCKAWAY, N.J., (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a bioelectronic technology ...